What the business is, and whether it's a good one at a fair price.
Operates a chain of multi-speciality hospitals in Delhi-NCR and Uttar Pradesh providing tertiary and quaternary healthcare, with over 3,200 beds across nine facilities and FY26 revenue of ₹1,207 crore. Three new hospitals commenced operations during FY26 — a 300-bed facility in Delhi's Model Town (July 2025), a 400-bed hospital in Faridabad Sector 20 (September 2025), and a 150-bed Shantived hospital in Agra (February 2026) — and these newer units together contributed ₹753 crore (22% of group revenue) in Q4 FY26. A 250-bed under-construction super-speciality hospital in Gurugram Sector 40 was acquired for ~₹200 crore (₹100 crore upfront plus ₹100 crore finishing capex) and is targeted to be operational by April 2027 with expected ARPOB above ₹50,000. The network recorded FY26 occupancy of around 68% and ARPOB of ₹33,124, while CGHS rate revision from December 2025 is expected to add ~5% to revenue and ~3% to EBITDA. Government payers (CGHS and similar schemes) make up ~35% of revenue, with management targeting a reduction to ~25% over two years by reweighting the payer mix toward the newer hospitals. Management is targeting 5,000 beds within three years — currently over 3,200 — with roughly 70% of additions via acquisitions and 30% greenfield, at ~₹75 lakh per bed for the Noida Extension and Greater Noida brownfield projects. The largest cost line is other operating expenses at 36.9% of revenue, followed by employee costs at 19.4% and depreciation at 7.3%.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from YATHARTH HOSP & TRA C S L's filed financials and exchange disclosures
YATHARTH HOSP & TRA C S L is a Healthcare Services company listed on NSE and BSE, trading under the symbol YATHARTH.
Yes. Over the trailing twelve months YATHARTH HOSP & TRA C S L reported a net profit of ₹174 Cr on revenue of ₹1,334 Cr.
Not in the latest reported year — YATHARTH HOSP & TRA C S L's dividend payout for FY26 was nil.
No. Debt stands at 0.14× equity, and it carries net debt of ₹32 Cr. That is lower than 65% of its 24 Hospital peers.
On trailing P/E, YATHARTH HOSP & TRA C S L ranks 19 of 30 in Hospital — cheaper than 38% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session YATHARTH HOSP & TRA C S L moves 1.26% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by YATHARTH HOSP & TRA C S L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.